Elevated Capital Advisors, LLC

Holdings History for AbbVie Inc. - Common Stock (ABBV)

Symbol: ABBV on NYSE
Investment type: Equity / Common Stock

Shares, Excluding Options vs Price

Value, Excluding Options

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
31 Dec 2025	0.5%	-0.19%	$2,164,812	9,474	-3,583	-27%	$228.50	Q4 2025
30 Sep 2025	0.75%	+0.04%	$3,023,106	13,057	+650	+5.2%	$231.53	Q3 2025
30 Jun 2025	0.73%	0%	$2,599,603	12,407	0		$209.53	Q2 2025
31 Mar 2025	0.73%	-0.04%	$2,599,603	12,407	-682		$209.53	Q1 2025
31 Dec 2024	0.63%	+0.07%	$2,325,900	13,089	+1,377	+12%	$177.70	Q4 2024
30 Sep 2024	0.61%	+0.1%	$2,312,982	11,712	+1,995	+21%	$197.49	Q3 2024
30 Jun 2024	0.47%	-0.44%	$1,666,622	9,717	-8,988	-48%	$171.52	Q2 2024
31 Mar 2024	0.98%	+0.02%	$3,406,164	18,705	+324	+1.8%	$182.10	Q1 2024
31 Dec 2023	0.89%	+0.01%	$2,848,538	18,381	+266	+1.5%	$154.97	Q4 2023
30 Sep 2023	0.92%	+0.06%	$2,700,166	18,115	+1,131	+6.7%	$149.06	Q3 2023
30 Jun 2023	0.76%	+0.03%	$2,288,280	16,984	+755	+4.7%	$134.73	Q2 2023
31 Mar 2023	0.93%	+0%	$2,586,436	16,229	+36	+0.22%	$159.37	Q1 2023
31 Dec 2022	1%	+0.19%	$2,616,885	16,193	+3,019	+23%	$161.61	Q4 2022
30 Sep 2022	0.7%	+0%	$1,768,000	13,174	+65	+0.5%	$134.20	Q3 2022
31 Mar 2022	0.7%	+0.03%	$2,125,000	13,109	+521	+4.1%	$162.10	Q1 2022
30 Sep 2021	0.47%	+0.03%	$1,358,000	12,588	+918	+7.9%	$107.88	Q3 2021
31 Mar 2021	0.49%	+0.16%	$1,272,000	11,670	+3,738	+47%	$109.00	Q1 2021
31 Dec 2020	0.37%	-0.03%	$850,000	7,932	-734	-8.5%	$107.16	Q4 2020
30 Sep 2020	0.41%	-0%	$857,000	8,666	-30	-0.34%	$98.89	Q3 2020
30 Jun 2020	0.46%	+0.2%	$817,000	8,696	+3,715	+75%	$93.95	Q2 2020
31 Dec 2019	0.49%	0%	$441,000	4,981	0		$88.54	Q4 2019
31 Mar 2019	0.79%	0%	$827,000	10,103	0		$81.86	Q1 2019

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.